Veteran genomics leader joins Illumina to advance global medical strategy Illumina chief commercial officer to depart for role as a life science tools company CEO  SAN DIEGO — Today, Illumina, Inc. (NASDAQ: ILMN) announced the appointment of Eric D. Green, M.D., Ph.D., as Chief Medical Officer (CMO), effective February 2. In this role reporting to […]

Planned Leadership Transition Positions Company for Growth Company Expects to Exceed Revenue and Cash Guidance for the Full Year 2025 BILLERICA, Mass. — Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its Board of Directors (the “Board”) has appointed Everett Cunningham […]

The formation of the executive team marks a significant milestone as NanoTemper builds on its strong foundation of scientific excellence and customer-centered innovation to advance biophysical characterization solutions that simplify complex science and accelerate drug discovery. The NanoTemper executive leadership team is led by Stefan Duhr, Co-Founder and Chief Executive Officer, and includes: ● Eva Lindskog […]

WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that the Board has elected Dr. Martin D. Madaus as Chair of the Board, effective March 13, 2026. As previously communicated1, Tony Hunt is retiring from his role as Executive Chair and member of the Board of Directors […]

RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the appointment of Simon Dingemans to its Board of Directors, effective January 2, 2026. Mr. Dingemans is an accomplished executive with extensive global leadership experience across healthcare, […]

Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial Flexibility BroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board on Growth and Operating Opportunities  HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), today announced it entered into an agreement with BroadOak […]

CAMBRIDGE, Ontario–ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Doug Wright has been appointed Chief Executive Officer (CEO) and a member of its Board of Directors, commencing on or before January 14, 2026. Mr. Wright’s appointment follows a comprehensive search led by ATS’ Board of Directors. “We are very pleased […]

BICO Group AB today announces the appointment of Jesper Hagberg as Chief Operations & Digital Officer. Jesper Hagberg brings over 25 years of experience as CIO, CDO and Transformation Leader, driving major transformation programs across global organizations. Most recently, he served as Program Director at FLSmidth Group and previously as CIO/CDO and PMO at Jula […]

BICO Group AB today announces the appointment of Ewa Linsäter as Chief Financial Officer. She will succeed Jacob Thordenberg, who has decided to leave BICO to pursue his career outside the Group. Ewa Linsäter has 15+ years’ experience of working as a Chief Financial Officer (CFO) whereof the last six years at Elos Medtech. Prior […]

Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth William Feehery to step down as CEO on December 31, 2025 Company reaffirms full year 2025 financial outlook RADNOR, Pa. — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, announced today that it has appointed Jon […]